Will This Chronic Cough Drug Succeed Where Others Failed?

(MedPage Today) -- SAN FRANCISCO--A drug targeting so-called P2X3 receptors as therapy for refractory chronic cough showed good efficacy and relatively few adverse effects in a phase II trial called SOOTHE, a researcher said here--results...